The Lancet Neurology Andersen, G, Damgaard, D, Weitzel, P V & NAVIGATE ESUS Investigators 2018, ' Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial ', Lancet Neurology, vol. 17, no. 12, pp. 1053-1060 . https://doi.org/10.1016/S1474-4422(18)30319-3 Department of Medicine Publications